2005
DOI: 10.1111/j.1365-2133.2005.06811.x
|View full text |Cite
|
Sign up to set email alerts
|

A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir

Abstract: We conclude that fatty acid metabolism and in particular CPT-1 may be an excellent target for treatment of psoriasis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
27
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(28 citation statements)
references
References 23 publications
1
27
0
Order By: Relevance
“…Additional evidence for the importance of fatty acid metabolism in the skin is the increased activity of the fatty acid enzyme CPT1 in psoriasis. Blocking CPT1 activity, key for b-oxidation, reduces keratinocyte differentiation and proliferation in psoriatic skin (Caspary et al 2005). These findings support a role for fatty acid metabolism in fueling cellular processes in the skin and its appendages.…”
Section: Potential Additional Roles Of Adipocytes In the Skinsupporting
confidence: 58%
“…Additional evidence for the importance of fatty acid metabolism in the skin is the increased activity of the fatty acid enzyme CPT1 in psoriasis. Blocking CPT1 activity, key for b-oxidation, reduces keratinocyte differentiation and proliferation in psoriatic skin (Caspary et al 2005). These findings support a role for fatty acid metabolism in fueling cellular processes in the skin and its appendages.…”
Section: Potential Additional Roles Of Adipocytes In the Skinsupporting
confidence: 58%
“…It has also been suggested that epidermal fatty acid-binding protein contributes to the pathogenesis of psoriasis through activation of the NF-kB signalling pathway 63 , a powerful transcriptional regulator of pro-inflammatory genes. Furthermore, etomoxir-mediated b-oxidation inhibition is beneficial in the treatment of psoriasis 64 . We provide a mechanistic link connecting enhanced fatty acid b-oxidation within epidermal cells to their immune function that acts to direct leukocyte recruitment.…”
Section: Discussionmentioning
confidence: 99%
“…Etomoxir has been shown to irreversibly inhibit the activity of carnitine palmitoyltransferase 1 (CPT1), the rate-limiting enzyme of FAO ( Fig. 1 ), in primary human fi broblasts ( 40 ). In our experiments, pretreatment of cells with etomoxir resulted in a concentrationdependent reduction of the abundance of FAO metabolites directly derived from enzymatic conversions within the palmitate ␤ -oxidation ( Fig.…”
Section: Application Potential Of the Assaymentioning
confidence: 66%